AptaBio Therapeutics Inc. (KOSDAQ:293780)
6,970.00
+380.00 (5.77%)
Oct 16, 2026, 3:30 PM KST
| Market Cap | 195.81B -9.3% |
| Revenue (ttm) | 4.75B +52.9% |
| Net Income | -14.87B |
| EPS | -540.42 |
| Shares Out | 28.09M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 50,041 |
| Open | 6,950.00 |
| Previous Close | 6,590.00 |
| Day's Range | 6,730.00 - 7,150.00 |
| 52-Week Range | 3,870.00 - 10,890.00 |
| Beta | 0.89 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |